R&D | November 14, 2025
UK MHRA finds gut microbiome research unreliable across labs
False positive rates?ranged from 0% to 41%, meaning some labs incorrectly identified bacteria that weren’t present in the sample
False positive rates?ranged from 0% to 41%, meaning some labs incorrectly identified bacteria that weren’t present in the sample
The inclusion of broad-spectrum sunscreen in the WHO EML and EMLc follows an application submitted in November 2024 by the Global Albinism Alliance
Test delivers results in just 18 minutes, enabling faster laboratory workflows and patient management during outbreaks
Breakthrough expands proactive TB screening from birth to 15 years, ensuring faster and more accurate diagnosis
WHO’s global SPECS 2030 target to increase effective refractive error coverage by 40% by 2030
RedHill will receive $500,000 in guaranteed payments, including a $250,000 upfront payment and $250,000 in fixed payments due within 18 months
Delegates also visited Emami’s WHO-GMP-certified manufacturing plant and Zandu Foundation for Healthcare farms for hands-on exposure to quality practices,
This certification validates the plant’s robust capabilities in manufacturing a wide range of sterile dosage forms
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
A new weapon in the global fight against malaria
Subscribe To Our Newsletter & Stay Updated
